G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 113 filers reported holding G1 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $819,550 | -80.0% | 150,930 | -54.1% | 0.01% | -77.3% |
| Q3 2022 | $4,107,000 | +1087.0% | 328,800 | +871.1% | 0.02% | +1000.0% |
| Q4 2021 | $346,000 | -89.3% | 33,859 | -86.0% | 0.00% | -90.5% |
| Q3 2021 | $3,247,000 | -57.4% | 241,953 | -30.3% | 0.02% | -60.4% |
| Q2 2021 | $7,616,000 | -7.8% | 347,124 | +1.1% | 0.05% | -11.7% |
| Q1 2021 | $8,261,000 | +77.5% | 343,366 | +32.7% | 0.06% | +53.8% |
| Q4 2020 | $4,655,000 | +1978.1% | 258,777 | +1237.1% | 0.04% | +1850.0% |
| Q3 2020 | $224,000 | +7.2% | 19,354 | +2.2% | 0.00% | -66.7% |
| Q1 2020 | $209,000 | -50.4% | 18,943 | -25.3% | 0.01% | -53.8% |
| Q1 2019 | $421,000 | – | 25,366 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |